Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Neurology
•
Vascular Neurology
Would you consider starting dual antiplatelet therapy in a patient with evidence of petechial hemorrhage post stroke secondary to ICAD?
Related Questions
What would be the clinical benefit of multiphase CTA over CTP?
When do you consider treating intracerebral hemorrhage associated with cerebral amyloid angiopathy as an inflammatory CAA?
Do you avoid SSRIs in patients with a history of RCVS?
How do you address incidental small cerebellar infarcts seen on MRI?
Do you usually recommend PFO closure for patients with frequent migraines with aura?
When do you re-image patients with a diagnosis of venous sinus thrombosis?
In patients with embolic stroke and a PFO, how often do you go beyond venous Doppler of the lower extremities to screen for DVT (e.g. MRV or CTV abdomen and pelvis)?
Can bleeding risk when switching from VKA treatment to a NOAC in frail, elderly patients be accurately compared if individual times in therapeutic range while on VKA treatment are not captured?
Would you change an elderly, frail patient with atrial fibrillation who is already on a NOAC to VKA treatment?
What is your approach to the management of asymptomatic intracranial atherosclerosis discovered during the workup of an acute stroke?
